| Literature DB >> 21823041 |
Joseph Shatzel1, Kimberly Wooten, Anita Ankola, Richard T Cheney, Carl D Morrison, Joseph J Skitzki.
Abstract
Although rare, extra-pulmonary inflammatory myofibroblastic tumors (IMTs) are becoming increasingly recognized. While surgical resection is currently an effective and accepted treatment for IMTs, the optimal management of unresectable or residual IMTs remains a clinical dilemma. We present the case of an incompletely resected IMT treated successfully with anti-inflammatory therapy alone, and describe the rationale for this approach.Entities:
Mesh：
Substances：
Year: 2011 PMID： 21823041 DOI： 10.1007/s10147-011-0297-0
Source DB: PubMed Journal: Int J Clin Oncol ISSN： 1341-9625 Impact factor: 3.402